May 6, 2022May 6, 2022May 6, 20220000070318false00000703182022-05-062022-05-060000070318exch:XNYSus-gaap:CommonStockMember2022-05-062022-05-060000070318us-gaap:SeniorNotesMemberexch:XNYS2022-05-062022-05-06


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 _______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 _______________
Date of Report: May 6, 2022
(Date of earliest event reported)
 _______________
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
 
Nevada
 1-7293 95-2557091
(State of Incorporation) (Commission File Number) (IRS Employer
Identification Number)
14201 Dallas Parkway
Dallas, TX 75254
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)		Name of each exchange
on which registered
Common stock, $0.05 par valueTHCNYSE
6.875% Senior Notes due 2031THC31NYSE
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07.
Submission of Matters to a Vote of Security Holders.
The 2022 Annual Meeting of Shareholders of Tenet Healthcare Corporation (the “Company”) was held on May 6, 2022. Below are the final voting results from the meeting.

1.    The Company’s shareholders elected the following nominees to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal:
FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
Ronald A. Rittenmeyer
86,706,445
1,288,932
47,943
6,803,958
J. Robert Kerrey
85,492,681
2,503,766
46,873
6,803,958
James L. Bierman
86,145,447
1,850,863
47,010
6,803,958
Richard W. Fisher
87,315,477
679,897
47,946
6,803,958
Meghan M. FitzGerald
86,411,402
1,590,382
41,536
6,803,958
Cecil D. Haney
86,575,789
1,421,227
46,304
6,803,958
Christopher S. Lynch
87,317,502
678,600
47,218
6,803,958
Richard J. Mark
87,318,842
677,309
47,169
6,803,958
Tammy Romo
87,293,370
708,767
41,183
6,803,958
Saumya Sutaria
87,925,812
79,060
38,448
6,803,958
Nadja Y. West
86,580,713
1,417,636
44,971
6,803,958

2.    The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation:

FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
85,140,056
2,843,356
59,908
6,803,958

3.    The Company’s shareholders approved the First Amendment to the Tenet Healthcare 2019 Stock Incentive Plan.

FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
85,632,550
2,347,730
63,040
6,803,958

4    The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2022:

FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
93,860,868
910,170
76,240
-0-



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TENET HEALTHCARE CORPORATION
Date: May 9, 2022By:
/s/ THOMAS ARNST
Name: Thomas Arnst
Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary